A naturally occurring nonaprenylsulfate (1) and its synthetic analogue (2) were synthesized from substituted phenolic precursors in three steps with an overall yield of 40-45%. Both compounds exhibited potent anti-inflammatory activity against 5-lipoxygenase, and potent brine shrimp lethality. They also showed moderate anti-oxidant activity in the super oxide radical scavenging model. Nonaprenylsulfate (1) showed moderate inhibition of paw edema in Freund's Complete Adjuvant (FCA) induced model of arthritis, thus confirming its anti-inflammatory activity.
Inflammation is a complex biological response that occurs following the exposure of vascular tissue to harmful stimuli, such as pathogens, damaged cells, or irritants [1] . It is a protective mechanism by the organism to counter injurious stimuli and to initiate the healing process. It has also been manifested in recent years that chronic low-grade tissue inflammation is related to many metabolic disorders such as obesity, insulin resistance and atherosclerosis [2, 3] . Thus, there is a great demand for non-steroidal anti-inflammatory agents, especially those derived from natural origin. Nonaprenylhydroquinone sulfate (1) is a potent -1, 3-fucosyltransferase VII inhibitor isolated from an Australian sponge Sarcotragus sp [4, 5] .
-1, 3-Fucosyltransferase VII is a proinflammatory protein, responsible for P-and E-selection ligand synthesis and it plays a role in the control of leukocyte recruitment during the inflammation process [6] . It is also known to play a role in the metastasis of colorectal and prostate cancers. Hence, -1, 3-fucosyltransferase VII has been considered to be one of the favorite targets for developing anti-inflammatory and anticancer drugs. As part of our search for potent anti-inflammatory and anticancer agents, we selected nonaprenyl aromatic sulfates for further investigation. However, limited availability of the raw material, coupled with the tedious process for the isolation of these minor nonaprenylhydroquinone sulfates from natural sources prompted us to develop a cost effective synthetic process to explore their in vitro and in vivo efficacy. Nonaprenylhydroquinone sulfate (1) and nonaprenylphenol sulfate (2) were synthesized and tested for their anti-inflammatory, brine shrimp lethality and anti-oxidant activities.
O-Acetylhydroquinone (3) or phenol (4) was reacted with solanesol in the presence of boron trifluoride etherate [7] to obtain nonaprenyl phenols 5 and 6, respectively. The nonaprenylated phenolic compounds 5 and 6 were subjected to O-sulfonation using sulfur trioxide-pyridine complex [8] to yield nonaprenyl sulfates 7 and 8, respectively. Compounds 7 and 8 were then converted to their sodium salts 1 and 2, respectively, using sodium hydroxide in methanol [9] , as summarized in scheme 1. The IR, 1 H NMR and 13 C NMR spectral data obtained for sodium nonaprenylhydroquinone sulfate (1) closely matched those reported for its natural counterpart [5] . The structure of sodium nonaprenylphenolic sulfate (2) was confirmed by comparison of its spectral data with that of 1. Both these compounds were tested for their in vitro potential against 5-lipoxygenase and brine shrimp. Their efficacy was further tested in vivo in the FCA-induced model of arthritis.
Compounds 1 and 2 showed potent 5-lipoxygenase inhibition, with half inhibitory concentrations (IC 50 values) of 1.1 g/mL and 3.40 g/mL, respectively. In comparison, the positive control, bisdemethylcurcumin, showed an IC 50 value of 3.5 g/mL. The data are summarized in Table 1 . Interestingly, compounds 1 and 2 also showed potent brine shrimp lethality with IC 50 values of 2.3 g/mL and 4.0 g/mL, respectively, and their efficacy is comparable with that of the positive control, podophyllotoxin (IC 50 3.80 g/mL), as summarized in Table 1 . In addition, compounds 1 and 2 exhibited potent anti-oxidant activity comparable with that of vitamin C (IC 50 102.4 g/mL), with IC 50 values of 50.7 g/mL and 84.0 g/mL, respectively ( Table 1 ). The efficacy of 1 was further evaluated in vivo in the FCA induced arthritis model of rats in comparison with a positive control, namely prednisolone. The nonaprenylsulfate 1 showed 26.4% inhibition of paw edema at 50 mg/kg daily dose when compared with the control group of animals. The positive control, prednisolone, in comparison showed 38.0% improvement at 10 mg/kg bodyweight, as shown in Figure 1 . The foregoing results thus suggest that sodium nonaprenylhydroquinone NPC Natural Product Communications 2013 Vol. 8 No. 11 1595 -1598 sulfate (1) and its analogs have the potential for further development for therapeutic intervention against inflammation mediated diseases.
Experimental
General: IR, Perkin-Elmer (model spectrum BX) FT-IR; NMR, Bruker Avance AV 400 MHz NMR; Mass studies were performed on a LC-MS system equipped with an Agilent 1100 series LC-MS detector and 1100 series Agilent HPLC pump and Waters Xevo G2 QTof system. CC, silica gel (ACME, 100-200 mesh); TLC, silica gel pre-coated plates. The plates were eluted with a mixture of n-hexane/ethyl acetate (9:1) and visualized by immersing the plate in vanillin sulfuric acid reagent, followed by heating at 110°C. Nitro blue tetrazolium (NBT) was obtained from Sigma Chemicals (USA). Brine shrimp (Artemia salina) eggs were obtained from Argent Chemical Laboratories, Redmond (USA). The in vivo efficacy study was performed in the animal facility of Laila Impex R & D Center, Vijayawada, India.
Procedure for preparation of compounds 5 and 6:
To a mixture of (0.01 mol) each of O-acetylhydroquinone (3) or phenol (4) and solanesol (0.01 mol) in 20 mL of carbon tetrachloride was added BF 3 etherate (0.004 mol) and the reaction mixture stirred at room temperature. After 1 h, the contents were poured into ice-cold water and extracted with ethyl acetate. The organic layer was washed with brine, dried over sodium sulfate and concentrated. The crude residue was subjected to CC using n-hexane/ethyl acetate mixtures as eluents. The fractions eluted with 2-5% ethyl acetate/n-hexane mixtures were monitored by TLC and the pure fractions were combined and evaporated to yield prenylated compounds (5 or 6). 
2-Nonaprenyl

Procedure for preparation of nonaprenylsulfates 7 and 8:
The nonaprenylphenol 5 or 6 (0.001 mol) was dissolved in dry tetrahydrofuran (25 mL) and treated with sulfurtrioxide-pyridine complex (0.0015 mol), pyridine (0.013 mol) and DMAP (10 mg). The reaction mixture was stirred at room temperature for 2 h. The reaction mixture was then poured into ice-cold water and extracted with diethyl ether. The organic layer was washed with brine, dried over sodium sulfate and concentrated under vacuum at room temperature to yield nonaprenylphenol sulfonic acid 7 or 8. (7) 
2-Nonaprenyl-4-acetoxyphenol sulfonic acid
Preparation of compound 1:
To a solution of 2-nonaprenyl-4acetoxyphenylsulfonic acid (7, 0.5 g, 0.00059 mol) in methanol (3 mL) was added NaOH (47 mg, 0.00117 mol) and the reaction mixture was stirred overnight at room temperature. Then, the reaction mixture was poured into ice-cold water, neutralized with 2N HCl, and extracted with diethyl ether. The organic layer was washed with brine, dried over sodium sulfate and concentrated. The crude was dissolved in 4 mL of methanol, then treated with 23 mg of sodium hydroxide, stirred overnight and concentrated to obtain the sodium salt of nonaprenylhydroquinone sulfonic acid (1) in 90% yield (426 mg). (1) 
Sodium salt nonaprenylhydroquinone sulfonic acid
Preparation of compound 2:
To a solution of 2-nonaprenylphenyl sulfonic acid (8, 0.5 g, 0.00063 mol) in methanol (3 mL) was added NaOH (25 mg, 0.00117 mol) and the reaction mixture was stirred overnight at room temperature. Then the reaction mixture was poured into ice-cold water and the contents extracted with diethyl ether. The organic layer was washed with brine, dried over sodium sulfate and concentrated to obtain the sodium salt of 2-(nonaprenyl)phenyl sulfonic acid (2) in 90% yield (397 mg). 
Sodium salt of 2-(nonaprenyl)phenyl sulfonic acid
5-Lipoxygenase activity:
5-Lipoxygenase inhibitory activity was measured using the method of Schewe et al. [10] , modified by Reddanna et al. [11] . The assay mixture contained 80 M linoleic acid and sufficient potato 5-lipoxygenase in 50 mM phosphate buffer (pH 6.3). The reaction was initiated by the addition of enzyme buffer mix to linoleic acid and the enzyme activity was monitored as the increase in absorbance at 234 nm. The reaction was monitored for 120 sec and the inhibitory potential of the test substances 1 or 2 was measured by incubating various concentrations of test substances 2 min before the addition of linoleic acid. All assays were performed in triplicate. Percentage inhibition was calculated by comparing the slope of the curve obtained for test substances with that of the control.
Brine shrimp lethality bioassay: Brine shrimps (Artemia salina)
nauplii were hatched from eggs [12] in a conical shaped vessel (1 L) filled with sterile artificial sea water (prepared using sea salt 38g/L and pH adjusted to 8.5 using 1N NaOH) under constant aeration for 48 h. After hatching, 10 nauplii were drawn through a pipette and placed in each vial containing 4.5 mL brine solution and treated with various concentrations of test substances. The final volume was made up to 5 mL using brine solution. The cultures were maintained at 37°C for 24 h under an incandescent lamp. The surviving larvae were counted. Each experiment was conducted along with the control (vehicle treated), at various concentrations of the test substance with each set containing 6 tubes and means of the results were noted. The percentage lethality was determined by comparing the mean surviving larvae of test and control tubes. The LC 50 values were obtained from the plot drawn containing concentration (µg) verses percentage inhibition. Podophyllotoxin was used as a positive control. The results are summarized in Table  1 .
Superoxide radical scavenging activity:
Superoxide radical scavenging activities of compounds 1 and 2 were determined using the Nitro Blue Tetrazolium (NBT) photo reduction method of McCord and Fridovich [13] . The assay mixture containing EDTA (6.6 µM), NaCN (3 µg), riboflavin (2 µM), NBT (50 µM), test substance and phosphate buffer (58 m mol, pH 7.8) in a final volume of 3 mL in a tube was shaken well, and the optical density measured at 560 nm. Each tube was then uniformly illuminated with an incandescent lamp for 15 min, and the optical density was measured at 560 nm. The percentage inhibition of superoxide radical-generation was measured by comparing the absorbance values of the control and that of the test substance. The IC 50 values were obtained from a plot drawn of the concentration (µM) versus the percentage inhibition.
In vivo anti-inflammatory activity of nonaprenylsulfate (1) in the Freund's Complete Adjuvant (FCA) induced model of paw edema:
The anti-inflammatory efficacy of 1 was evaluated in vivo in the FCA induced arthritis model using Sprague Dawley rats. The rats of either sex were randomly selected and divided into 3 groups of 6 animals each [14] [15] . The animals of the treatment group were supplemented daily with a dose of 50 mg/kg body weight of 1 for 28 days. The positive control group was supplemented with prednisolone at 10 mg/kg dose. All supplements were diluted in 10 mL of 1% CMC for administration. The animals of the control group received the same volume of 1% CMC. On the 14th day, FCA was injected subcutaneously in the sub-plantar region of the left hind paw of each animal. At the end of the experiment, the animals were euthanized and liver tissue samples were excised and stored in aliquots at -80 o C. Blood samples were collected from each animal at regular intervals. The paw volumes were measured by plethysmography on the day of FCA injection and after 13 days of FCA inoculation. The difference in volume of edema at the day of FCA injection and at the 13 th day after induction is considered as the inflammatory response. The data are summarized in Figure 1 . The in vivo anti-inflammatory responses of 1 and prednisolone were estimated by calculating the percentage of inhibition of paw edema when compared with the CMC supplemented control. The nonaprenylsulfate 1 showed 26.4% inhibition of paw edema when compared with the control group of animals. The positive control, prednisolone, in comparison showed 38% improvement.
